Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Indian drugmaker Biological E. to make substance used in J&J's potential COVID-19 vaccine

08/13/2020 | 08:03am EDT
FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York

Indian drugmaker Biological E. Ltd will begin making a drug substance used in Johnson & Johnson's COVID-19 vaccine candidate that is in early to mid-stage trials, the companies said on Thursday.

J&J aims to produce more than 1 billion doses of its vaccine candidate, and has struck a similar deal with U.S.-based Emergent BioSolutions Inc to boost manufacturing. Large-scale trials for the potential vaccine, Ad26.COV2-S, are set to start by October.

Twenty-eight vaccine candidates are currently in human trials, according to the World Health Organization, as the global death toll from the novel coronavirus nears 750,000.

Biological E. Ltd in an email also said it has signed a licensing agreement with Houston-based Baylor College of Medicine to develop a COVID-19 vaccine.

Other Indian companies developing or manufacturing potential COVID-19 vaccines include the Serum Institute, Wockhardt Ltd, Cadila Healthcare Ltd and Panacea Biotec Ltd.

India on Thursday reported a record daily jump of 67,000 coronavirus infections, taking its total to nearly 2.4 million. It has the world's third-biggest case load after the United States and Brazil.

(Reporting by Anuron Kumar Mitra in Bengaluru)


© Reuters 2020
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC 0.01% 7867 Delayed Quote.7.37%
CADILA HEALTHCARE LIMITED -0.93% 611.4 Delayed Quote.29.45%
EMERGENT BIOSOLUTIONS INC. 5.98% 62 Delayed Quote.-30.80%
EURO / BRAZILIAN REAL (EUR/BRL) 0.15% 6.4139 Delayed Quote.1.05%
NOVAVAX, INC. 8.83% 131.69 Delayed Quote.18.10%
PANACEA BIOTEC LIMITED 1.41% 380.5 End-of-day quote.58.97%
WOCKHARDT LIMITED 0.89% 639.45 Delayed Quote.15.96%
Latest news "Companies"
07:28aCiti promotes Gutiérrez-Orrantia to head EMEA banking, capital markets and advisory -memo
RE
07:28aHYCROFT MINING  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
07:28aAT&T  : signs deal to combine media biz with Discovery
AQ
07:27aRYANAIR HLDGS  : Buy rating from Bernstein
MD
07:25aONDAS HOLDINGS INC.  : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07:24aHOSTESS BRANDS  : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
07:23aROYAL HELIUM LTD  : . Announces $10 Million "Bought Deal" Financing
AQ
07:22aTSX futures point to lower open as crude weakens
RE
07:22aSTEM  : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K/A)
AQ
07:21aMicrosoft says it investigated Gates' involvement with employee
RE
Latest news "Companies"